MedTrace Logo

Optimization of Cardioprotection in Diabetic Patients Undergoing Cardiac Surgery

NCT02407626 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2

Last updated 2018-03-09

No results posted yet for this study

Summary

This study evaluates the myocardial protection against perioperative ischemia comparing two standard anesthetic regimes in diabetic patients undergoing elective cardiac surgery. Half of the patients will receive volatile anesthesia while the other half will receive total intravenous anesthesia. Primary and secondary outcome parameters will be assessed after induction of anesthesia, at the end of the procedure and postoperative day 1 to 3.

Conditions

  • Myocardial Ischemia

Interventions

DRUG

Propofol

Total intravenous anesthesia is a clinical standard procedure

DRUG

Sevoflurane

Volatile anesthesia is a clinical standard procedure

Sponsors & Collaborators

  • University of Alberta

    collaborator OTHER

  • Triemli Hospital

    lead OTHER

Principal Investigators

  • Andreas Zollinger, MD · Institute of Anesthesiology and Intensive Care Medicine Triemli City Hospital Zurich

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
85 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2018-03-07
Completion
2018-03-07

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02407626 on ClinicalTrials.gov